The company said, “Kestra expects revenue for fiscal year ending April 30, 2025 to be in the range of $58.0 million to $58.5 million, representing growth of approximately 109% to 110% compared to fiscal year 2024.”
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMTS:
- Kestra Medical Technologies Ltd.: Positioned for Growth with Strong Financials and Innovative Market Strategy
- Kestra Medical Technologies: Strong Growth Potential Balanced by Current Valuation in MedTech Sector
- Kestra Medical initiated with a Buy at BofA
- Kestra Medical Technologies: Positioned for Growth in the Wearable Cardioverter Defibrillator Market
- Kestra Medical initiated with an Outperform at Wolfe Research